Trials / Completed
CompletedNCT04146103
A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH
Prospective Multicenter Open-label One Arm Trial Investigating a Pumpkin Seed, Isoflavonoid and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- Saint-Joseph University · Academic / Other
- Sex
- Male
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to assess the efficacy of a mix of Pumpkin Seed Extract, Soy Germ Isoflavonoids and Cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. The patients will be evaluated based on the severity of LUTS, urological quality of life, and erectile function.
Detailed description
This is a single-arm prospective open-label trial investigating a combination of pumpkin seed, isoflavonoid and cranberry mix in improving LUTS, urological quality of life, and erectile function in BPH patients. The compound will be administered orally two tablets daily for 3 months. Recruited patients will be seen at 3 visits: initial visit (visit 1), 1-month visit (visit 2) and 3-month visit (visit 3) and their data will be collected in a dedicated case report form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Novex | Novex® made of Pumpkin Seed Extract 550mg, Soy Germ Isoflavonoids 50 mg and Cranberry 50mg. The dose is 2 tablets/day taken orally. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-01-31
- Completion
- 2019-03-31
- First posted
- 2019-10-31
- Last updated
- 2019-10-31
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT04146103. Inclusion in this directory is not an endorsement.